91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

The Investment Catalyst: A showcase of chemistry-led innovation for the investment community

19 May 2022 18:00-21:00, London, United Kingdom


Introduction
The 91AV presents to you the 10th edition of the Investment Catalyst. The event will be held hybrid on 19 May 2022 either at Burlington House or online, with 8 companies selected to pitch following a competitive application series.
 
Our aim is to connect the UK’s leading chemistry-focused start-ups and scale-ups with angel and early stage investors through the 91AV's vast network.
 
Over the last six years, the Investment Catalyst has presented 63 leading innovators using chemistry to revolutionise life sciences, energy supply, construction, food and drink, the automotive industry and more. We have seen our cohort of businesses raise a total of £4.5m in funding from attending investors, and we’re thrilled to have seen an incredible exit from one of our finalists at a phenomenal £623m!

The event is open to investors, angel syndicates and groups and VC funds.  If you do not fit into one of these categories we reserve the right to cancel your registration.

Registration for the event is free

91AV-led innovation represents a broad and compelling opportunity for early-stage investors as it is integral to supporting an array of sectors and focuses. Businesses using chemistry at the centre of their technology offer possibilities that can drastically impact and improve the lives and work of citizens and communities everywhere, and together we are delighted to create a platform to showcase innovators first-hand to potential investors.

The 91AV currently supports over 300 small businesses across the UK by providing networking opportunities, grants and funding support, and help with recruitment and business promotion through their EnterprisePlus scheme.
Speakers
Albotherm, United Kingdom

Albotherm are developing technologies that control the world’s most powerful natural resource, the light of the sun. Albotherm have developed coatings that reversibly transition from transparent to opaque white as they heat up, reflecting the sun's rays and passively cooling buildings to reduce carbon emissions.


Cambridge Photon Technology, United Kingdom

Cambridge Photon Technology (CPT) is creating advanced materials that will significantly raise the power of standard photovoltaic modules. CPT’s approach solves a pressing problem for the solar PV industry by increasing performance without requiring new module designs or production processes, allowing manufacturers to gain a competitive advantage and raise their margins.


Exactmer, United Kingdom

Pioneers in exact polymer synthesis, Exactmer is redefining what is possible in controlling monomer sequences; developing a Nanostar Sieving technology to produce high-purity polymers bound for use in medicine.


Figura Analytics, United Kingdom

Figura Analytics use Nanopore technology to screen a sample of liquid in minutes, measuring the size, concentration and shape of every particle in the sample. This enables users to monitor consistency and quality as well as spotting abnormalities quickly. Our technology has applications in industry and MedTech.


Low Sulphur Fuels, United Kingdom

Low Sulphur Fuels (LSF) have developed a unique chemical recycling process to convert used oils, rubber tyres and plastics and produce circular outputs that are used to make new plastics, chemicals, rubber tyres, biofuels, and other products.


MediSieve, United Kingdom

MediSieve is a London-based Biotech start-up developing Magnetic Haemofiltration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used to (1) treat disease, (2) to the safety and efficacy of other therapies, and (3) to deliver drugs.


Oxford nanoSystems, United Kingdom

Oxford nanoSystems (OnS) have developed advanced and highly innovative coating technologies that reduce the cost per kW of alkaline hydrogen electrolysers.


Somnus Scientific, United Kingdom

Somnus Scientific is a multi-award winning start-up diagnostics company with new IP being developed in the fields of sedation and anaesthesia.  Somnus will fulfil the global unmet need of point-of-care measurement of propofol.



Venue
The 91AV

The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom


This event is a hybrid event. For those attending in-person, venue details are as below. Virtual attendance will take place via the 91AV’s virtual conference platform.
 
We are actively planning to hold this event in a hybrid format. Should the event move to be held in virtual-only format, any in-person delegate registrations will be refunded for the difference between in-person and virtual registration fees.

Useful links

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*